Cosimo Colletta
Omegna, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic liver disease and type 2 diabetes.
Journal: Frontiers in endocrinology
Published: November 20, 2024
Efficacy and Safety of Sofosbuvir and Ribavirin in an Italian Cohort of HCV Genotype 2 Elderly Cirrhotic Patients.
Journal: The Eurasian journal of medicine
Published: June 15, 2022
Lifestyle and silymarin: a fight against liver damage in NAFLD associated - prediabetic disease.
Journal: Journal of diabetes and metabolic disorders
Published: November 29, 2019
Severity of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus: Relationship between Nongenetic Factors and PNPLA3/HSD17B13 Polymorphisms.
Journal: Diabetes & metabolism journal
Published: October 04, 2018
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial.
Journal: Hepatology (Baltimore, Md.)
Published: October 31, 2014
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program.
Journal: Journal of viral hepatitis
Published: July 16, 2014
Durability of the response to peginterferon-α2b and ribavirin in patients with chronic hepatitis C: a cohort study in the routine clinical setting.
Journal: European journal of gastroenterology & hepatology
Published: May 31, 2013
Fibrosis progression in HCV carriers with mild hepatitis who possess the high-repetition variant of the DRD4 gene, a genetic marker for binge-drinking and risk-seeking behavior: a longitudinal study.
Journal: Alcoholism, clinical and experimental research
Published: July 31, 2012
The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases.
Journal: Journal of medical virology
Published: March 21, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026